TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.